Taftrio Tablet

Taftrio Tablet is an antiretroviral drug containing Bictegravir, Emtricitabine, and Tenofovir Alafenamide. It is used in the treatment of HIV-1 infection. HIV-1 is a human immunodeficiency virus that attacks and weakens a person's immune system. This infection progressively weakens immunity, making patients more susceptible to opportunistic infections. Do not take this drug if you are allergic to Taftrio Tablet or its ingredients. During the early stages of HIV-1 treatment, some patients may experience an inflammatory response to opportunistic infections, a condition called immune reconstitution syndrome. This can occur after starting this drug or other antiretroviral therapies. Monitor for any signs of worsening infections or inflammatory symptoms and report these to your doctor. Inform your doctor if you have a history of heart failure, pancreatitis, bone disease, fractures, or liver or kidney problems. Patients with pancreatitis or at risk of pancreatitis should take this combination cautiously. During treatment, your doctor may periodically monitor your blood counts, bone mineral density, and liver and kidney parameters to prevent serious complications. Adults of childbearing potential should use effective contraception to prevent unwanted pregnancy. If you are pregnant or think you might be pregnant, your doctor may suggest an alternative treatment, as this combination regimen is not recommended during early pregnancy. Breastfeeding is not recommended due to the possible transmission of HIV-1 infection from mother to baby. Inform your doctor about all your medications, including prescription drugs, over-the-counter medicines, and herbal supplements, to ensure no potential interactions.

Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection

Taftrio Tablet combines integrase strand transfer inhibitors and nucleoside, nucleotide analogue reverse transcriptase inhibitors. It increases the number of CD4 T cells and stimulates the immune system to fight against infections. Thereby, it reduces the viral load of HIV in the blood and decreases the severity of HIV infection.

Take the Taftrio Tablet as advised by your physician. Swallow the tablets whole and intact. This tablet should be taken with food. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the medicine if your doctor advises you to stop.

Side Effects are unwanted symptoms caused by medicines. Although all medicines cause side effects, not everyone gets them. Serious Bone loss Worsening of Hepatitis B Kidney injury Immune reconstitution syndrome Lactic acidosis Liver toxicity Common Depression Abnormal dreams Headache Dizziness Diarrhea Feeling sick (Nausea) Tiredness (Fatigue)

To prevent the spread of HIV-1 infection, avoid sharing needles or syringes, which can transmit HIV-1 infections easily. It's necessary for individuals who use injectable drugs to use sterile needles and syringes and never share them with others. Personal items like toothbrushes, razor blades, or anything with body fluids or blood should also be avoided. They should not be shared because HIV-1 can be present in blood and certain body fluids, and sharing these items could mainly transmit the virus. Do not have any sex without protection. It is necessary to practice safe sex using a polyurethane condom or latex to lower the risk of sexual contact with semen, vaginal secretions, or blood. If you remember to take a Taftrio Tablet for the entire day, take your usual dose the next day. However, do not double-dose yourself. Do not store this tablet in a moist place like a bathroom cabinet or near the kitchen sink. Keep your tablet in a tightly closed container. Do not accept if the seal over the bottle opening is broken or missing. This medicine was prescribed for your specific condition. Please do not use it for other conditions. Do not give this tablet to others, even if they have the same symptoms like you have. It may harm them.